drugset / Trial / NCT00282828

Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder

NCT00282828

RandomizedParallel-groupTriple-blindTreatment

Summary

This study will compare the effectiveness of either adding clonazepam or placebo to standard treatment or switching to venlafaxine in treating generalized social anxiety disorder in individuals who have not responded to treatment with sertraline.

Timeline

Start
2006-03
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonazepam Small molecule
Subject Venlafaxine Small molecule
Background Sertraline Small molecule

Indications